# ClinicalTrials.gov record NCT04734730

> PeptideScanner retained ClinicalTrials.gov record NCT04734730 at 2026-07-30T16:25:18.017Z. Its registry update date was 2026-01-28, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct04734730-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04734730-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04734730-leuprolide-v1.json
- Content SHA-256: `e7290f3252a5bca17dc3bba137085779a80e4c5ca87ba02e2f9ac2898a0b5ffe`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04734730 ([`ctg-observation-nct04734730-2026-01-28-371cd5ffd153`](#source-ctg-observation-nct04734730-2026-01-28-371cd5ffd153))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04734730 at 2026-07-30T16:25:18.017Z. Its registry update date was 2026-01-28, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct04734730-2026-01-28-371cd5ffd153`](#source-ctg-observation-nct04734730-2026-01-28-371cd5ffd153))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04734730 at 2026-07-30T16:25:18.017Z. Its registry update date was 2026-01-28, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct04734730-2026-01-28-371cd5ffd153`](#source-ctg-observation-nct04734730-2026-01-28-371cd5ffd153))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04734730-2026-01-28-371cd5ffd153`](#source-ctg-observation-nct04734730-2026-01-28-371cd5ffd153))

## Sources

<a id="source-ctg-observation-nct04734730-2026-01-28-371cd5ffd153"></a>
- **ClinicalTrials.gov record NCT04734730 · retained source version 2026-01-28:371cd5ffd1536aeb267768453ada839f374fc6a92a3707ef2563b4e9b5441b68** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04734730) (`ctg-observation-nct04734730-2026-01-28-371cd5ffd153`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04734730." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04734730-leuprolide-v1.json SHA-256: e7290f3252a5bca17dc3bba137085779a80e4c5ca87ba02e2f9ac2898a0b5ffe.